The interaction between heart and brain becomes increasingly important as the underlying mutual mechanisms become better understood. The specialty that deals with the brain-heart connection has become known as neurocardiology. Strokes, cerebral microvascular disease, dementia resulting from heart disease and cardiac abnormalities are examples of the many points of contact between neurology and cardiology.
Approximately 30% of strokes are related to heart disease, including atrial fibrillation, congestive heart failure, valvular diseases, acute myocardial infarction with left ventricular thrombus, patent foramen ovale, among others. Strokes can also occur in the context of processes such as cardiac catheterization and coronary artery bypass procedures.
The future of therapeutic approaches in neurocardiology lies both in new diagnostic, prevention and treatment approaches that take into account the current chronic and degenerative vascular disorders and the interactions of various medicated and non-medicated treatments.
In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with neurocardiology. Experimental studies, network meta-analysis, randomized controlled trials, systematic reviews and meta-analysis, umbrella reviews, meta-epidemiologic studies, cross-sectional studies, diagnosis, treatment, management, prevention and clinical research for early diagnosis and prognosis are welcome.
The areas to be covered in this research topic may include, but are not limited to:
1) An update or new knowledge about the pathophysiology and cellular and molecular mechanisms linked to brain-heart and related diseases.
2) New biological functions and signaling transduction linked to neurocardiology and related diseases.
3) The role o frisk factors in the pathogenesis of the metabolic syndrome and its pathophysiological mechanisms linked to cardioneurology.
4) New therapeutic strategies related to vascular cardioneurology: pharmacological therapy, exercise, diet, gene therapy, cell therapy and etc.
5) Clinical devices and biomarkers for early diagnosis and prognosis of cardioneurovascular diseases.
The interaction between heart and brain becomes increasingly important as the underlying mutual mechanisms become better understood. The specialty that deals with the brain-heart connection has become known as neurocardiology. Strokes, cerebral microvascular disease, dementia resulting from heart disease and cardiac abnormalities are examples of the many points of contact between neurology and cardiology.
Approximately 30% of strokes are related to heart disease, including atrial fibrillation, congestive heart failure, valvular diseases, acute myocardial infarction with left ventricular thrombus, patent foramen ovale, among others. Strokes can also occur in the context of processes such as cardiac catheterization and coronary artery bypass procedures.
The future of therapeutic approaches in neurocardiology lies both in new diagnostic, prevention and treatment approaches that take into account the current chronic and degenerative vascular disorders and the interactions of various medicated and non-medicated treatments.
In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with neurocardiology. Experimental studies, network meta-analysis, randomized controlled trials, systematic reviews and meta-analysis, umbrella reviews, meta-epidemiologic studies, cross-sectional studies, diagnosis, treatment, management, prevention and clinical research for early diagnosis and prognosis are welcome.
The areas to be covered in this research topic may include, but are not limited to:
1) An update or new knowledge about the pathophysiology and cellular and molecular mechanisms linked to brain-heart and related diseases.
2) New biological functions and signaling transduction linked to neurocardiology and related diseases.
3) The role o frisk factors in the pathogenesis of the metabolic syndrome and its pathophysiological mechanisms linked to cardioneurology.
4) New therapeutic strategies related to vascular cardioneurology: pharmacological therapy, exercise, diet, gene therapy, cell therapy and etc.
5) Clinical devices and biomarkers for early diagnosis and prognosis of cardioneurovascular diseases.
